Cargando…

Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease

INTRODUCTION: Information about patient preferences for the treatment of anaemia associated with chronic kidney disease (CKD) is scarce. Hence, our aim was to examine how patients with non-dialysis-dependent CKD valued attributes of alternative hypothetical anaemia treatments. METHODS: A discrete ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alexandre, Ana Filipa, Morga, Antonia, Thomas, Caitlin, Krucien, Nicolas, Tervonen, Tommi, Jiletcovici, Alina, Marsh, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898369/ https://www.ncbi.nlm.nih.gov/pubmed/36449257 http://dx.doi.org/10.1007/s12325-022-02367-z

Ejemplares similares

Willingness to Wait for a Vaccine Against COVID-19: Results of a Preference Survey
por: Tervonen, Tommi, et al.
Publicado: (2020)

Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment
por: Thomas, Caitlin, et al.
Publicado: (2022)

Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis
por: Tervonen, Tommi, et al.
Publicado: (2021)

Clinical factors for predicting cardiovascular risk, need for renal replacement therapy, and mortality in patients with non–dialysis-dependent stage 3–5 chronic kidney disease from the Salford Kidney Study
por: Filipa Alexandre, Ana, et al.
Publicado: (2023)

How do study design features and participant characteristics influence willingness to participate in clinical trials? Results from a choice experiment
por: Thomas, Caitlin, et al.
Publicado: (2022)

Population pharmacokinetics of roxadustat in Japanese dialysis‐dependent chronic kidney disease patients with anaemia
por: Takada, Akitsugu, et al.
Publicado: (2021)

From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk Tradeoffs
por: Tervonen, Tommi, et al.
Publicado: (2019)

Impact of gender and dialysis adequacy on anaemia in peritoneal dialysis
por: Ryta, Alicja, et al.
Publicado: (2017)

Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies
por: Akizawa, Tadao, et al.
Publicado: (2019)

Clinicians' preferences for managing aneurysmal subarachnoid hemorrhage using endothelin receptor antagonists
por: Heidenreich, Sebastian, et al.
Publicado: (2023)

Discrete Choice Experiment to Understand Japanese Patients’ and Physicians’ Preferences for Preventive Treatments for Migraine
por: Seo, Jaein, et al.
Publicado: (2023)

A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia
por: Kalra, Philip A., et al.
Publicado: (2016)

Molidustat for the treatment of renal anaemia in patients with non-dialysis-dependent chronic kidney disease: design and rationale of two phase III studies
por: Yamamoto, Hiroyasu, et al.
Publicado: (2019)

Patients’ with obstructive sleep apnoea syndrome (OSAS) preferences and demand for treatment: a discrete choice experiment
por: Krucien, Nicolas, et al.
Publicado: (2013)

Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2020)

Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia
por: Zhu, Xin-Wang, et al.
Publicado: (2021)

Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy
por: Minutolo, Roberto, et al.
Publicado: (2022)

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
por: Brooks, Anne, et al.
Publicado: (2019)

Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment
por: Pinto, Cathy Anne, et al.
Publicado: (2021)

Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2023)

Patient and Public Preferences for Coordinated Care in Switzerland: Development of a Discrete Choice Experiment
por: Nicolet, Anna, et al.
Publicado: (2022)

Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland
por: Mathieu, Claudine M, et al.
Publicado: (2008)

Polymorphism in the GATM Locus Associated with Dialysis-Independent Chronic Kidney Disease but Not Dialysis-Dependent Kidney Failure
por: Šalamon, Špela, et al.
Publicado: (2021)

Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment
por: Collacott, Hannah, et al.
Publicado: (2023)

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
por: Qunibi, Wajeh Y., et al.
Publicado: (2011)

Lower starting dose of roxadustat in non-dialysis-dependent chronic kidney disease patients with anaemia: a study protocol for a randomised, multicentre, open-label study
por: Li, Ping, et al.
Publicado: (2023)

Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests
por: Gelhorn, Heather, et al.
Publicado: (2022)

The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial
por: Fox, Robert J, et al.
Publicado: (2022)

Efficacy & safety of continuous erythropoietin receptor activator (CERA) in treating renal anaemia in diabetic patients with chronic kidney disease not on dialysis
por: Vankar, Sameer G., et al.
Publicado: (2014)

Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”
por: Brooks, Anne B., et al.
Publicado: (2020)

Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]
por: Louis, Edouard, et al.
Publicado: (2022)

Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO(2)VATE trials
por: Eckardt, Kai-Uwe, et al.
Publicado: (2020)

C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
por: Roger, Simon D., et al.
Publicado: (2011)

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
por: Sarnak, Mark J, et al.
Publicado: (2023)

Acute peripheral pulmonary embolism attributed to autoimmune haemolytic anaemia: a case report
por: Xu, Jing, et al.
Publicado: (2020)

The Preference for Joint Attributions Over Contrast-Factor Attributions in Causal Contrast Situations
por: Wang, Moyun, et al.
Publicado: (2019)

Assessing Patient Preferences in Rare Diseases: Direct Preference Elicitation in the Rare Chronic Kidney Disease, Immunoglobulin A Nephropathy
por: Marsh, Kevin, et al.
Publicado: (2021)

Dialysis Decision Making and Preferences for End-of-Life Care: Perspectives of Pakistani Patients Receiving Maintenance Dialysis
por: Saeed, Fahad, et al.
Publicado: (2020)

Chronic kidney disease under non-dialysis dependent, hemodialysis, peritoneal dialysis and kidney transplant treatment: Body composition data
por: Bellafronte, Natália Tomborelli, et al.
Publicado: (2020)

Preference for pharmaceutical formulation and treatment process attributes
por: Stewart, Katie D, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6dlevrn5uirjinmstie92gers8